| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70771-1598-6 | 70771-1598 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | OSELTAMIVIR ACID | SUSPENSION | ORAL | 20210805 | N/A | ANDA | ANDA209113 | Cadila Healthcare Limited | OSELTAMIVIR PHOSPHATE | 6 mg/mL | 60 mL in 1 BOTTLE (70771-1598-6) |
| 70710-1165-6 | 70710-1165 | HUMAN PRESCRIPTION DRUG | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | FOR SUSPENSION | ORAL | 20170914 | N/A | ANDA | ANDA209113 | Zydus Pharmaceuticals USA Inc. | OSELTAMIVIR PHOSPHATE | 6 mg/mL | 1 BOTTLE in 1 CARTON (70710-1165-6) / 60 mL in 1 BOTTLE |
| 68788-7600-6 | 68788-7600 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | Oseltamivir Phosphate | FOR SUSPENSION | ORAL | 20200213 | N/A | ANDA | ANDA209113 | Preferred Pharmaceuticals Inc. | OSELTAMIVIR PHOSPHATE | 6 mg/mL | 1 BOTTLE in 1 CARTON (68788-7600-6) / 60 mL in 1 BOTTLE |